Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2006; 12(29): 4721-4726
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4721
Published online Aug 7, 2006. doi: 10.3748/wjg.v12.i29.4721
Table 2 Allele frequency of CCR5 variants in chronic HCV patients and healthy controls
| CCR5 | HCV Patients(n = 252) | Healthy Controls(n = 408) | P value |
| Wt/wt | 247 (98%) | 405 (99.3%) | 0.07 |
| Δ32mt carrier | 5 (1.9%) | 3 (0.7%) | 0.3 |
| Wt/Δ32 | 3 (1.2%) | 3 (0.7%) | 0.2 |
| aΔ32mt/Δ32mt | 2 (0.7%) | - | 0.1 |
- Citation: Goyal A, Suneetha P, Kumar G, Shukla DK, Arora N, Sarin SK. CCR5Δ32 mutation does not influence the susceptibility to HCV infection, severity of liver disease and response to therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(29): 4721-4726
- URL: https://www.wjgnet.com/1007-9327/full/v12/i29/4721.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i29.4721